>>> Why "Over-Sourcing" is Costing Your R&D
The nature of clinical trials, with unpredictable patient enrolment, protocol amendments and changing timelines, often necessitates significant over-sourcing of comparator drugs and ancillary supplies.
This leads to two critical problems:
- Financial Loss: millions of dollars in unused or expired products must be destroyed, representing a direct loss of capital that could be used for other strategic initiatives
- Environmental Impact: the disposal of unused pharmaceuticals adds unnecessary strain to global waste management systems, negatively impacting your company’s environmental footprint and Environmental, Social and Governance (ESG) reporting
ClientPharma addresses this challenge by applying the disciplined, lean methodology of our veteran leadership. We recognize that waste management begins long before product destruction. It starts with intelligent, focused sourcing.
>>> Beyond Compliance: The ClientPharma ROI
Partnering with ClientPharma for your clinical supply and waste management services offers clear, measurable advantages.
These directly impact your bottom line and public commitments:
- Direct R&D Reinvestment: the value reclaimed from unused materials can be immediately cycled back into ongoing research and development, effectively expanding your R&D budget without requiring new capital
- ESG Reporting & Reputation: demonstrate verifiable progress toward your corporate environmental and sustainability goals by actively reducing pharmaceutical waste
- Operational Certainty: work with a disciplined, Veteran-Owned team that applies meticulous planning to eliminate unnecessary steps, reducing the risk of costly last minute supply delays that lead to additional waste
Our aim is to understand your goals and to work to minimize waste, allowing you to reinvest those savings back into your R&D initiatives.